Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

Abstract

These data suggest that ISG inducibility is important for the treatment response and that ribavirin may improve outcomes by enhancing hepatic gene responses to peginterferon. Collectively, these mechanisms may provide a molecular basis for the improved efficacy of combination therapy.